The Tyrosine Kinase Inhibitor Dasatinib impedes adaptive cell surveillance in peripheral lymph nodes

被引：0
|
作者：
Carvoeiro, Daniela Claudino [1 ]
Marcos-Jimenez, Ana [2 ]
Munoz-Calleja, Cecilia [2 ,3 ]
Stein, Jens Volker [1 ]
机构：
[1] Univ Fribourg, Dept Oncol Microbiol & Immunol, Fribourg, Switzerland
[2] La Princesa Hosp IIS IP, Biomed Res Inst, Dept Immunol, Madrid, Spain
[3] Inst Salud Carlos III, CIBER Infect Dis CIBERINFECC, Madrid, Spain
来源：
EUROPEAN JOURNAL OF IMMUNOLOGY | 2024年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
1435 - P2.
引用
收藏
页码：1099 / 1099
页数：1
相关论文
共 50 条
  • [1] A CASE OF TYROSINE KINASE INHIBITOR (DASATINIB)-INDUCED ANGIOEDEMA
    Peterson, J.
    Toro, J.
    Welch, N.
    Lalmuanpuii, J.
    Tarbox, J.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2023, 131 (05) : S110 - S110
  • [2] Inhibition of PVR with a Tyrosine Kinase Inhibitor, Dasatinib, in the Swine
    Umazume, Kazuhiko
    Liu, LanHsin
    Scott, Patrick A.
    de Castro, Juan P. Fernandez
    McDonald, Kevin
    Kaplan, Henry J.
    Tamiya, Shigeo
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (02) : 1150 - 1159
  • [3] The tyrosine kinase inhibitor dasatinib (SPRYCEL) inhibits chondrocyte activity and proliferation
    Vandyke, K.
    Fitter, S.
    Zannettino, A. C. W.
    BLOOD CANCER JOURNAL, 2011, 1 : e2 - e2
  • [4] The Tyrosine Kinase Inhibitor Dasatinib Decreases Osteoclast Formation and Activity in vitro
    Vandyke, K.
    Dewar, A. L.
    Davis, A. N.
    Fiuer, S.
    Hughes, T. P.
    To, L. B.
    Zannettino, A. C. W.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 : S260 - S261
  • [5] The tyrosine kinase inhibitor dasatinib inhibits the functions of human phagocytes in vitro
    Futosi, K.
    Nemeth, T.
    Mocsai, A.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2011, 41 : 48 - 48
  • [6] The tyrosine kinase inhibitor dasatinib (SPRYCEL) inhibits chondrocyte activity and proliferation
    K Vandyke
    S Fitter
    A C W Zannettino
    Blood Cancer Journal, 2011, 1 : e2 - e2
  • [7] The Btk tyrosine kinase is a major target of the Bcr-Abi inhibitor dasatinib
    Hantschel, Oliver
    Rix, Uwe
    Schmidt, Uwe
    Buerckstuemmer, Tilmann
    Kneidinger, Michael
    Schuetze, Gregor
    Colinge, Jacques
    Bennett, Keiryn L.
    Ellmeier, Wilf Ried
    Valent, Peter
    Superti-Furga, Giulio
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (33) : 13283 - 13288
  • [8] Dasatinib: a potential tyrosine kinase inhibitor to fight against multiple cancer malignancies
    Akash Fauziya
    Arif Gupta
    Shadaan Nadaf
    Nazeer Ahmad
    Mohammad Hasan
    Amirhossein Imran
    Gaurav Kumar Sahebkar
    Prashant Jain
    Farhan J. Kesharwani
    Medical Oncology, 40
  • [9] Dasatinib: a potential tyrosine kinase inhibitor to fight against multiple cancer malignancies
    Fauziya
    Gupta, Akash
    Nadaf, Arif
    Ahmad, Shadaan
    Hasan, Nazeer
    Imran, Mohammad
    Sahebkar, Amirhossein
    Jain, Gaurav Kumar
    Kesharwani, Prashant J.
    Ahmad, Farhan
    MEDICAL ONCOLOGY, 2023, 40 (06)
  • [10] The effect of dasatinib, a novel tyrosine kinase inhibitor, on the regression of pulmonary fibrosis in mice
    Kayalar, Ozgecan
    Yilmaz, Oznur
    Oztay, Fusun
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
12345